Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Panacea Life Sciences's shares outstanding was 16M at Mar 31, 2024. For fiscal 2023 it was 17M, up 11.9% from the year before. The highest annual figure on record is 18M in fiscal 2021.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | 17M | +11.9% |
| FY2022 | Dec 31, 2022 | 15M | -16.6% |
| FY2021 | Dec 31, 2021 | 18M | +5.3% |
| FY2020 | Dec 31, 2020 | 17M | +1297.2% |
| FY2019 | Dec 31, 2019 | 1M | +611.6% |
| FY2018 | Dec 31, 2018 | 0M | +12.3% |
| FY2017 | Dec 31, 2017 | 0M | +76.6% |
| FY2016 | Dec 31, 2016 | 0M | +3653.6% |
| FY2015 | Dec 31, 2015 | 0M | +15.6% |
| FY2014 | Dec 31, 2014 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | 16M | +10.2% |
| Q4 FY2023 | Dec 31, 2023 | 17M | +12.1% |
| Q3 FY2023 | Sep 30, 2023 | 17M | +11.8% |
| Q2 FY2023 | Jun 30, 2023 | 18M | +17.9% |
| Q1 FY2023 | Mar 31, 2023 | 15M | +1.4% |
| Q4 FY2022 | Dec 31, 2022 | 15M | -7.2% |
| Q3 FY2022 | Sep 30, 2022 | 15M | -30.5% |
| Q2 FY2022 | Jun 30, 2022 | 15M | -11.5% |
| Q1 FY2022 | Mar 31, 2022 | 15M | -32.6% |
| Q4 FY2021 | Dec 31, 2021 | 16M | -5.3% |
| Q3 FY2021 | Sep 30, 2021 | 21M | +26.4% |
| Q2 FY2021 | Jun 30, 2021 | 17M | 0.0% |
| Q1 FY2021 | Mar 31, 2021 | 22M | +1253.7% |
| Q4 FY2020 | Dec 31, 2020 | 17M | +1025.6% |
| Q3 FY2020 | Sep 30, 2020 | 17M | +1116.0% |
| Q2 FY2020 | Jun 30, 2020 | 17M | +1116.0% |
| Q1 FY2020 | Mar 31, 2020 | 2M | +132.4% |
| Q4 FY2019 | Dec 31, 2019 | 2M | +722.7% |
| Q3 FY2019 | Sep 30, 2019 | 1M | +709.4% |
| Q2 FY2019 | Jun 30, 2019 | 1M | +746.1% |
| Q1 FY2019 | Mar 31, 2019 | 1M | +330.9% |
| Q4 FY2018 | Dec 31, 2018 | 0M | +17.6% |
| Q3 FY2018 | Sep 30, 2018 | 0M | +14.7% |
| Q2 FY2018 | Jun 30, 2018 | 0M | +9.7% |
| Q1 FY2018 | Mar 31, 2018 | 0M | +6.8% |
| Q4 FY2017 | Dec 31, 2017 | 0M | +3.2% |
| Q3 FY2017 | Sep 30, 2017 | 0M | +0.4% |
| Q2 FY2017 | Jun 30, 2017 | 0M | +268.4% |
| Q1 FY2017 | Mar 31, 2017 | 0M | +7756.8% |
| Q4 FY2016 | Dec 31, 2016 | 0M | +6472.5% |
| Q3 FY2016 | Sep 30, 2016 | 0M | +6431.3% |
| Q2 FY2016 | Jun 30, 2016 | 0M | +1637.9% |
| Q1 FY2016 | Mar 31, 2016 | 0M | +1.6% |
| Q4 FY2015 | Dec 31, 2015 | 0M | +35.0% |
| Q1 FY2015 | Mar 31, 2015 | 0M | – |
| Q4 FY2014 | Dec 31, 2014 | 0M | – |
| Q3 FY2014 | Sep 30, 2014 | 0M | – |
| Q2 FY2014 | Jun 30, 2014 | 0M | – |
See a number that looks wrong?